MITOCHONDRIAL COMPLEX III DEFICIENCY (disorder)
|
0.530 |
GeneticVariation
|
disease |
BEFREE |
Novel Homozygous Variant in TTC19 Causing Mitochondrial Complex III Deficiency with Recurrent Stroke-Like Episodes: Expanding the Phenotype.
|
29961508 |
2018 |
MITOCHONDRIAL COMPLEX III DEFICIENCY (disorder)
|
0.530 |
GeneticVariation
|
disease |
BEFREE |
Phenotypic variation of TTC19-deficient mitochondrial complex III deficiency: a case report and literature review.
|
25899669 |
2015 |
MITOCHONDRIAL COMPLEX III DEFICIENCY (disorder)
|
0.530 |
GeneticVariation
|
disease |
BEFREE |
Mutations in TTC19 cause mitochondrial complex III deficiency and neurological impairment in humans and flies.
|
21278747 |
2011 |
MITOCHONDRIAL COMPLEX III DEFICIENCY (disorder)
|
0.530 |
Biomarker
|
disease |
CTD_human |
|
|
|
MITOCHONDRIAL COMPLEX III DEFICIENCY (disorder)
|
0.530 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
MITOCHONDRIAL COMPLEX III DEFICIENCY (disorder)
|
0.530 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2
|
0.400 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes.
|
27604308 |
2016 |
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2
|
0.400 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mutations in TTC19 cause mitochondrial complex III deficiency and neurological impairment in humans and flies.
|
21278747 |
2011 |
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2
|
0.400 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2
|
0.400 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2
|
0.400 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2
|
0.400 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Neurodegenerative Disorders
|
0.320 |
Biomarker
|
group |
BEFREE |
TTC19 deficiency is a progressive neurodegenerative disease associated with isolated mitochondrial respiratory chain (MRC) complex III deficiency and loss-of-function mutations in the TT19 gene in the few patients reported so far.
|
25887401 |
2015 |
Neurodegenerative Disorders
|
0.320 |
Biomarker
|
group |
BEFREE |
TTC19 has been reported to be a causative gene of a neurodegenerative disease in Italian and Portuguese families and to be involved in the pathogenesis of mitochondrial respiratory chain complex III (cIII) deficiency.
|
24397319 |
2014 |
Neurodegenerative Disorders
|
0.320 |
Biomarker
|
group |
CTD_human |
Mutations in TTC19 cause mitochondrial complex III deficiency and neurological impairment in humans and flies.
|
21278747 |
2011 |
Mitochondrial Diseases
|
0.310 |
Biomarker
|
group |
BEFREE |
One of the mitochondrial disease genes recently discovered associated to encephalopathy and mitochondrial complex III (cIII) deficiency is TTC19.
|
29243944 |
2018 |
Mitochondrial Diseases
|
0.310 |
Biomarker
|
group |
GENOMICS_ENGLAND |
Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes.
|
27604308 |
2016 |
nervous system disorder
|
0.310 |
GeneticVariation
|
group |
BEFREE |
TTC19 mutations constitute a rare cause of CIII deficiency and are associated with neurological disorders in childhood and adulthood.
|
25652355 |
2015 |
nervous system disorder
|
0.310 |
Biomarker
|
group |
CTD_human |
Mutations in TTC19 cause mitochondrial complex III deficiency and neurological impairment in humans and flies.
|
21278747 |
2011 |
Mitochondrial Diseases
|
0.310 |
Biomarker
|
group |
GENOMICS_ENGLAND |
|
|
|
Leigh Disease
|
0.300 |
Biomarker
|
disease |
CLINGEN |
Novel Homozygous Variant in TTC19 Causing Mitochondrial Complex III Deficiency with Recurrent Stroke-Like Episodes: Expanding the Phenotype.
|
29961508 |
2018 |
LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY
|
0.300 |
Biomarker
|
disease |
CLINGEN |
Novel Homozygous Variant in TTC19 Causing Mitochondrial Complex III Deficiency with Recurrent Stroke-Like Episodes: Expanding the Phenotype.
|
29961508 |
2018 |
Leigh Syndrome Due To Mitochondrial Complex II Deficiency
|
0.300 |
Biomarker
|
disease |
CLINGEN |
Novel Homozygous Variant in TTC19 Causing Mitochondrial Complex III Deficiency with Recurrent Stroke-Like Episodes: Expanding the Phenotype.
|
29961508 |
2018 |
Leigh Syndrome due to Mitochondrial Complex III Deficiency
|
0.300 |
Biomarker
|
disease |
CLINGEN |
Novel Homozygous Variant in TTC19 Causing Mitochondrial Complex III Deficiency with Recurrent Stroke-Like Episodes: Expanding the Phenotype.
|
29961508 |
2018 |
Leigh Syndrome due to Mitochondrial Complex IV Deficiency
|
0.300 |
Biomarker
|
disease |
CLINGEN |
Novel Homozygous Variant in TTC19 Causing Mitochondrial Complex III Deficiency with Recurrent Stroke-Like Episodes: Expanding the Phenotype.
|
29961508 |
2018 |